Pandemic influenza is a strong motivator for participation in vaccine clinical trials among HIV-positive Canadian adults
{{output}}
Background: HIV-positive patients represent an immunosuppressed population at risk for severe influenza. In the event of a pandemic, such as 2009 H1N1, rapid implementation of vaccine clinical trials in target populations will be... ...
